SemperVirens Venture Capital

Type

Venture Capital

Status

Active

Location

San Mateo, United States

Total investments

49

Average round size

30M

Portfolio companies

32

Rounds per year

8.17

Lead investments

5

Follow on index

0.35

Areas of investment
InternetSoftwareInformation TechnologyHuman ResourcesArtificial IntelligenceHealth CareWellnessEnterprise SoftwarePersonal HealthEmployee Benefits

Investor highlights

Industry focus
Future of WorkHealthcareFintech
Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
49
Lead investments
5
Rounds per year
8.17
Follow on index
0.35
Investments by industry
  • Health Care (19)
  • Software (15)
  • Human Resources (13)
  • Wellness (9)
  • Employee Benefits (8)
  • Show 50 more
Investments by region
  • United States (43)
  • United Kingdom (2)
  • China (1)
Peak activity year
2021
Number of Unicorns
2
Number of Decacorns
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
4
Avg. valuation at time of investment
212M
Group Appearance index
0.98
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Midi Health 24 Apr 2024 Health Care, Medical, Women's Early Stage Venture 60M United States, Menlo Park, California
Murmur 23 Nov 2022 Seed 8M United States, Colorado, Denver
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.